Xiling Shen

Xiling Shen has a diverse work experience in various academic and research institutions. Currently, they serve as the CEO of xilis and the Chief Scientific Officer at the Terasaki Institute for Biomedical Innovation (TIBI), starting in November 2021. Prior to these roles, they worked as an Associate Professor at Duke University starting in July 2015. Xiling also held the position of Assistant Professor at Cornell University from an unknown start date until November 2021.

Xiling Shen attended Stanford University from 1997 to 2008. However, no specific degree or field of study is mentioned for this education period.